Sun Pharma and its agency of record Fingerpaint wanted to raise awareness for ILUMYA, and sought out a digital media solution capable of accelerating patient reach while maximizing media efficiencies.
Using Patient Modeled Audiences to plan their campaign and activate it across CTV, online video, and digital, as well as DeepIntent Outcomes to measure and optimize performance, they were able to increase verified patient reach by 5.7x while decreasing the cost-per-verified-patient by 83%.
As health marketing undergoes rapid disruption around privacy and identity, delivering personalized messaging at scale becomes a steeper challenge—and an even more important goal. It isn’t just about “selling” more products. It’s about finding new ways to reach people and improve health outcomes. At AdLab Health Marketing Summit, DeepIntent Founder and CEO Chris Paquette urged […]
Proven to drive audience quality (AQ) and script lift, DeepIntent Outcomes™ is the industry’s fastest measurement solution based on clinical data. Download our eBooklet for a look at how Outcomes helped some of the leading pharma brands achieve: 164% higher audience quality over the course of a campaign 27% higher script lift within the first […]
With the rapid rise of streaming in recent years, it’s a common misconception that older audiences are still spending the majority of their viewing time with linear TV — a belief that has kept most pharma advertising investments focused on traditional channels. As one of the most important demographics for pharma, we set out to […]
Sign up for the newsletter to ensure our latest whitepapers, research reports, and more are delivered to your inbox.
